Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SPRC
SPRC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SPRC News
Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes
Jan 16 2026
NASDAQ.COM
SciSparc Ltd. Acquires Endoscopy Patents, Shares Drop 12.07%
Jan 13 2026
Benzinga
SciSparc (SPRC) Faces Nasdaq Compliance Risk Due to Negative Equity
Jan 13 2026
seekingalpha
SciSparc Secures Israeli Patent Enhancing Opioid Efficacy
Dec 30 2025
Globenewswire
SciSparc Secures Israeli Patent Enhancing Opioid Efficacy
Dec 30 2025
Newsfilter
Ulta Beauty Stock Rises Approximately 6%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 05 2025
Benzinga
SciSparc Acquires 55% Stake in NeuroThera for 40% Equity
Dec 02 2025
Newsfilter
Reasons Behind Today's Increase in SciSparc Stock
Nov 26 2025
Benzinga
SciSparc Acquires MUSE™ Endoscopic Patent Portfolio to Expand Global Market Reach
Nov 26 2025
Newsfilter
Clearmind Medicine Submits Israeli Patent for Innovative Non-Hallucinogenic Neuroplastogen Therapy for Depression
Nov 16 2025
Globenewswire
N2OFF Finalizes Merger with Cancer Drug Discovery Firm Focused on Challenging Pancreatic and Lung Cancers
Oct 30 2025
Newsfilter
SciSparc Completes Acquisition of TSXV-Listed Company, Transferring Its Advanced Clinical Stage Pharmaceutical Portfolio
Oct 24 2025
Newsfilter
SciSparc Aims to Transform AI Drug Discovery with Quantum-Enhanced 3D Protein Modeling Technology
Oct 23 2025
Newsfilter
Clearmind Medicine Reveals Submission of U.S. Patent Application Aimed at Treating Binge Behavior Disorders
Oct 19 2025
Globenewswire
Wolfspeed Shares Surge Over 50%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 30 2025
Benzinga
SciSparc Shares Jump 50% in Pre-Market Following N2OFF's Approval of MitoCareX Acquisition
Sep 30 2025
NASDAQ.COM
Show More News
